Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lisziewicz

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Virology|April 1, 1997
Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infectionM Rosenzweig, D F Marks, D Hempel, et al.
Nucleic Acids Research|July 25, 1990
Transcriptional regulatory elements of the RAS2 gene of Saccharomyces cerevisiaeJ Lisziewicz, J Brown, D Breviario, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioatesJ Lisziewicz, D Sun, V Metelev, et al.
AIDS (London, England)|September 8, 2001
Direct analysis of mitochondrial toxicity of antiretroviral drugsA Foli, F Benvenuto, G Piccinini, et al.
Gene Therapy|January 1, 1994
Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gagF Lori, J Lisziewicz, J Smythe, et al.
Virology|August 1, 1996
Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoysM B Brother, H K Chang, J Lisziewicz, et al.
Journal of Virology|January 1, 1995
An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapyJ Lisziewicz, D Sun, B Trapnell, et al.
AIDS (London, England)|June 17, 1999
Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infectionJ Lieberman, L A Trimble, R S Friedman, et al.
Science (New York, N.Y.)|November 4, 1994
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replicationF Lori, A Malykh, A Cara, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Hybrid oligonucleotides: synthesis, biophysical properties, stability studies, and biological activityD Yu, R P Iyer, D R Shaw, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Virology|April 1, 1997
Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infectionM Rosenzweig, D F Marks, D Hempel, et al.
Nucleic Acids Research|July 25, 1990
Transcriptional regulatory elements of the RAS2 gene of Saccharomyces cerevisiaeJ Lisziewicz, J Brown, D Breviario, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1993
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioatesJ Lisziewicz, D Sun, V Metelev, et al.
AIDS (London, England)|September 8, 2001
Direct analysis of mitochondrial toxicity of antiretroviral drugsA Foli, F Benvenuto, G Piccinini, et al.
Gene Therapy|January 1, 1994
Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gagF Lori, J Lisziewicz, J Smythe, et al.
Virology|August 1, 1996
Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoysM B Brother, H K Chang, J Lisziewicz, et al.
Journal of Virology|January 1, 1995
An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapyJ Lisziewicz, D Sun, B Trapnell, et al.
AIDS (London, England)|June 17, 1999
Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infectionJ Lieberman, L A Trimble, R S Friedman, et al.
Science (New York, N.Y.)|November 4, 1994
Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replicationF Lori, A Malykh, A Cara, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Hybrid oligonucleotides: synthesis, biophysical properties, stability studies, and biological activityD Yu, R P Iyer, D R Shaw, et al.
Pageof 6